IDEXX Laboratories ($IDXX) Insider Trading & Smart Money Activity

IDEXX Laboratories, Inc. · Diagnostics & Research · Latest filing Oct 16, 2026

IDEXX Laboratories, Inc. ($IDXX) has 4 13F position changes and 1 analyst rating on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 4
Analyst ratings on file: 1

IDXX insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 4
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All IDXX insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Oct 16, 2026	Analyst	JP Morgan	Reiterates to Overweight		PT $750			Read
May 15, 2026	13F	Fundsmith	Reduced	-410.25K sh	$771.65M	+5.8%	+7.8%	Read
May 14, 2026	13F	Polen Capital Management	Reduced	-264.73K sh	$366.30M	+3.8%	+7.0%	—
May 8, 2026	13F	William Blair Investment Management	Reduced	-89.70K sh	$196.09M	-5.6%	+0.2%	Read
May 8, 2026	13F	William Blair Investment Management	Reduced	-89.70K sh	$193.92M	-5.6%	+0.2%	—

1W / 1M / 6M = how IDXX moved from the trade or filing date.

Institutions moving IDXX (13F)

Analyst ratings on IDXX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Oct 16, 2026	JP Morgan	Reiterates	Overweight	$775 → $750				Read

Frequently asked questions

Which institutions changed their IDXX positions?

Recent 13F filers moving the stock include William Blair Investment Management, Fundsmith and Polen Capital Management.

Other diagnostics & research stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text